KOMBINATIONSTUMORIMMUNTHERAPIE
European patent · EP3240801 · In force
Register entry
- Publication number
- EP3240801
- Application number
- EP15876030
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 22, 2015
- Published
- Nov 8, 2017
- Granted
- Jan 20, 2021
- Protection ends at the latest
- Dec 21, 2035
- Next annual fee due
- Dec 31, 2026
- IPC classes
- A61K 31/7125 (2006.01)C07K 14/56 (2006.01)A61P 35/00 (2006.01)C07K 16/28 (2006.01)
- Priority
- US 201462098568 P 31.12.2014US 201562106526 P 22.01.2015US 201562118165 P 19.02.2015
- PCT application
- PCT/US2015/067269 22.12.2015
- PCT publication
- WO2016/109310 07.07.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 9, 2026
Agent removed
- Representative
- TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly (removed)
Published in Swissreg on 09.04.2026
- Apr 9, 2026
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 09.04.2026
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Dec 1, 2021
Change
Published in Swissreg on 01.12.2021
- Feb 5, 2021
Agent entered
- Representative
- TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly
Published in Swissreg on 05.02.2021
1 earlier entry
- Jan 20, 2021
Granted
Published in Swissreg on 20.01.2021
Parties
Inventor
Cambridge, MA 02138, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.